"We Envision Growth Strategies Most Suited
to Your Business"
The Neonatal Intensive Care Unit (NICU) is a controlled, closely monitored environment where each clinical decision impacts patient outcomes. Here, precision-driven treatment is essential for premature and severely unwell neonates, where medicine and fragility collide. NICU catheters stand out as lifelines among the various devices that make this delicate balance possible, guaranteeing that even the infant patients receive the nutrition, hydration, and drugs they require to survive and grow.
NICU Catheters are specialized medical tubes made to fit the delicate physiology of newborns. Peripherally Inserted Central Catheters (PICCs), umbilical catheters, and other vascular access devices are examples of these. NICU catheters, in contrast to conventional medical equipment, need to be both flexible and durable in order to minimize discomfort and guarantee reliable performance. Their design prioritizes safety beyond all else.
The market for NICU catheters is evolving rather than merely expanding. The need for equipment that can match the accuracy and sensitivity needed in intensive care settings is growing along with neonatal care. Products that lower problems, increase usability, and improve patient outcomes are becoming more important to hospitals and healthcare providers.
Fortune Business Insights estimates the market for NICU catheter to grow from USD 512.8 million in 2025 to USD 833.3 million by 2034, with a significant CAGR of 5.6% over the forecast period.
BD is based in New Jersey, U.S. and was established in 1897. The focus is on medical devices, life sciences, and interventional. BD provides newborns with vascular access systems, stabilizing devices, and peripherally placed central catheters. To address the significant risk of bloodstream infections in NICUs, BD is actively researching infection-prevention solutions, such as antimicrobial-coated catheters. To lower the chance of catheter dislodgment, they provide sophisticated securement devices.
Teleflex Incorporated was established in 1943 with its headquarters located in Pennsylvania, U.S. The focus is on vascular access, interventions, anesthesia, and surgery. Teleflex provides midlines, complete insertion kits for newborns, and peripherally placed central catheters. In order to facilitate real-time PICC navigation and enhance vascular access procedures, Teleflex introduced the next-generation Arrow VPS Rhythm DLX device and NaviCurve stylet in Canada in October 2024.
ICU Medical, Inc. is a U.S.-based company and was established in 1984. The firm has its focus on critical care, vascular access, and infusion therapy. It expanded the newborn vascular portfolio by acquiring Smiths Medical in 2022. The firm provides neonatal vascular access devices, catheter fastening, and closed-system IV connectors. By marketing its Clave needlefree IV connector technology, NanoClave manifolds, and SwabCap sanitizing caps to lower catheter-related bloodstream infections, the firm focuses on reducing risks in newborns.
Vygon SAS is based in Ecouen, France and was established in 1962. It is a family-run single-use medical device company with focus on neonatal, critical care, anesthetic, and enteral. Vygon provides introducers for premature babies, insertion sets, and neonatal/perinatal PICCs. In February 2026, by acquiring Stilleto®, a cutting-edge prolonged dwell catheter intended for better insertion and patient outcomes, Vygon bolstered its position in vascular access.
Cook Medical LLC was established in 1963 with headquarters in Indiana, U.S. It mainly focuses on minimally invasive devices in critical care, vascular, urology, and OB/GYN. Neonatal PICC and central lines are covered by the Critical Care division. Cook provides nephrostomy drainage for newborns, tunneled central lines, and peripherally implanted central catheters. In an effort to lower catheter-related bloodstream infections, the business kept obtaining 510(k) approvals for its Spectrum Central Venous Catheter series.
Medtronic plc, headquartered in Dublin, Ireland was founded in 1949. The company mainly focuses on cardiovascular, medical surgical, neurology, and diabetes. Patient monitoring and respiratory interventions are used to care for newborns. Neonatal cannulae, Affinity Pixie™ oxygenation devices and arterial filters for pediatric cardiac bypass, and Microstream™ capnography for preterm and new ventilation monitoring are the products in its NICU portfolio. Medtronic’s Crescent RA jugular dual lumen catheter was approved by the CE Mark in February 2025.
Argon Medical Devices, Inc. was established in 1972 with headquarters present in Texas, U.S. Vascular access, biopsy, drainage, and critical care are prioritized, with global production. Argon provides procedural accessories and central venous catheters for neonatal vascular access.
With headquarters in Melsungen, Germany, B. Braun Melsungen AG was established in 1839. It majorly focuses on vascular access, anesthesia, infusion therapy, and surgery. B.Braun provides central venous catheters, infusion systems, and neonatal PICC/Central securement devices for pediatric care. B.Braun recently developed silicone and polyurethane-based catheters that provide improved biocompatibility and less vein discomfort.
Founded in 1988, AngioDynamics, Inc. has its headquarters located in New York, U.S. The company has its expertise in peripheral vascular, oncology/surgery, and vascular access. AngioDynamics provides central venous catheters and peripherally placed central catheters for neonatal vascular access.
Poly Medicure Limited was established in 1995 with headquarters present in Haryana, India. The company mainly focuses on infusion therapy, vascular access, dialysis, and surgery. It exports to more than 125 nations with US FDA, WHO-GMP, and CE certifications. The firm provides insertion sets, umbilical catheters, and neonatal PICCs. Poly Medicure has created a special line of neonatal devices, such as PU Umbilical Catheters, which are composed of polyurethane and have atraumatic, soft-tipped designs for babies and are intended for long-term vascular access with DEHP-free materials.
In NICU, size does not determine relevance. Despite being tiny and frequently invisible, catheters are vital for life-saving procedures. The top companies that know how to strike a balance between innovation and dependability are the ones driving the industry. Developing solutions that satisfy the highest standards of infant care requires ongoing research, clinical validation, and cooperation with medical professionals. Therefore, the industry’s capacity to combine advanced technology with compassionate care will determine its future. In conclusion, these devices will continue to be crucial in raising newborn survival rates and long-term results as research advances and healthcare systems change.
+1 833 909 2966 ( Toll Free ) (US)
sales@fortunebusinessinsights.com